Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK

A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

NCT00067951 ·Status: COMPLETED ·Phase: PHASE3

Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

NCT00551564 ·Status: COMPLETED ·Phase: PHASE1

Rosiglitazone on Microalbuminuria in Type 2 Diabetics

NCT00500955 ·Status: COMPLETED ·Phase: PHASE3

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

NCT00500331 ·Status: COMPLETED ·Phase: PHASE2

Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage

NCT01275794 ·Status: COMPLETED

MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).

NCT00754130 ·Status: COMPLETED ·Phase: PHASE1

Study In People With Type 2 Diabetes

NCT00196989 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)

NCT00543959 ·Status: TERMINATED ·Phase: PHASE2

Effect of Rosiglitazone

NCT00285142 ·Status: COMPLETED ·Phase: NA

RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes

NCT00379769 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes

NCT00856908 ·Status: COMPLETED ·Phase: PHASE2

Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects

NCT01690169 ·Status: COMPLETED ·Phase: PHASE1

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

NCT02958956 ·Status: COMPLETED

Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes

NCT00367055 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

NCT00997152 ·Status: TERMINATED ·Phase: PHASE2

Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study

NCT00481429 ·Status: WITHDRAWN

Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth

NCT00413335 ·Status: COMPLETED ·Phase: NA

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

NCT00318656 ·Status: COMPLETED ·Phase: PHASE4

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

NCT03392961 ·Status: COMPLETED ·Phase: PHASE1

Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving Rosiglitazone

NCT00746174 ·Status: COMPLETED ·Phase: PHASE4

To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes

NCT01176097 ·Status: COMPLETED ·Phase: PHASE1

A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM

NCT06199505 ·Status: COMPLETED ·Phase: PHASE2

A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus

NCT03985293 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

NCT00929539 ·Status: COMPLETED ·Phase: PHASE2

Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus

NCT00057317 ·Status: COMPLETED ·Phase: PHASE2